Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Calhoun

Showing results (71-80 of 188) with videos related to

Pageof 19
Sort By:
Expert Opinion on Pharmacotherapy|November 21, 2009
Reduction of blood pressure in patients with treatment-resistant hypertensionMaria Czarina Acelajado, David A Calhoun, Suzanne Oparil
Current Hypertension Reports|May 11, 2002
Resistant hypertensionDavid A Calhoun, Mohammad A Zaman, Mari K Nishizaka
Seminars in Nephrology|November 23, 2014
Pathophysiology and treatment of resistant hypertension: the role of aldosterone and amiloride-sensitive sodium channelsEric K Judd, David A Calhoun, David G Warnock
American Journal of Hypertension|June 24, 2016
Do We Need a New Definition of Hypertension After SPRINT?Ernesto L Schiffrin, David A Calhoun, John M Flack
American Journal of Hypertension|November 9, 2018
Resistant Hypertension: An UpdateDavid A Calhoun, Ernesto L Schiffrin, John M Flack
American Journal of Hypertension|October 24, 2003
Efficacy of low-dose spironolactone in subjects with resistant hypertensionMari Konishi Nishizaka, Mohammad Amin Zaman, David A Calhoun
Hypertension (Dallas, Tex. : 1979)|April 20, 2016
Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment FailureTanja Dudenbostel, Mohammed Siddiqui, Suzanne Oparil, et al.
Journal of Nature and Science|October 17, 2017
Refractory versus resistant hypertension: Novel distinctive phenotypesTanja Dudenbostel, Mohammed Siddiqui, Nitin Gharpure, et al.
American Journal of Hypertension|November 25, 2015
SPRINT Proves that Lower Is Better for Nondiabetic High-Risk Patients, but at a PriceErnesto L Schiffrin, David A Calhoun, John M Flack
Current Hypertension Reports|May 26, 2005
Aldosterone antagonism: an emerging strategy for effective blood pressure loweringMonique N Pratt-Ubunama, Mari K Nishizaka, David A Calhoun
Pageof 19

Showing results (71-80 of 188) with videos related to

Sort By:
Pageof 19
Expert Opinion on Pharmacotherapy|November 21, 2009
Reduction of blood pressure in patients with treatment-resistant hypertensionMaria Czarina Acelajado, David A Calhoun, Suzanne Oparil
Current Hypertension Reports|May 11, 2002
Resistant hypertensionDavid A Calhoun, Mohammad A Zaman, Mari K Nishizaka
Seminars in Nephrology|November 23, 2014
Pathophysiology and treatment of resistant hypertension: the role of aldosterone and amiloride-sensitive sodium channelsEric K Judd, David A Calhoun, David G Warnock
American Journal of Hypertension|June 24, 2016
Do We Need a New Definition of Hypertension After SPRINT?Ernesto L Schiffrin, David A Calhoun, John M Flack
American Journal of Hypertension|November 9, 2018
Resistant Hypertension: An UpdateDavid A Calhoun, Ernesto L Schiffrin, John M Flack
American Journal of Hypertension|October 24, 2003
Efficacy of low-dose spironolactone in subjects with resistant hypertensionMari Konishi Nishizaka, Mohammad Amin Zaman, David A Calhoun
Hypertension (Dallas, Tex. : 1979)|April 20, 2016
Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment FailureTanja Dudenbostel, Mohammed Siddiqui, Suzanne Oparil, et al.
Journal of Nature and Science|October 17, 2017
Refractory versus resistant hypertension: Novel distinctive phenotypesTanja Dudenbostel, Mohammed Siddiqui, Nitin Gharpure, et al.
American Journal of Hypertension|November 25, 2015
SPRINT Proves that Lower Is Better for Nondiabetic High-Risk Patients, but at a PriceErnesto L Schiffrin, David A Calhoun, John M Flack
Current Hypertension Reports|May 26, 2005
Aldosterone antagonism: an emerging strategy for effective blood pressure loweringMonique N Pratt-Ubunama, Mari K Nishizaka, David A Calhoun
Pageof 19